1. Home
  2. NC vs CRVS Comparison

NC vs CRVS Comparison

Compare NC & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NC
  • CRVS
  • Stock Information
  • Founded
  • NC 1913
  • CRVS 2014
  • Country
  • NC United States
  • CRVS United States
  • Employees
  • NC N/A
  • CRVS N/A
  • Industry
  • NC Coal Mining
  • CRVS Biotechnology: Pharmaceutical Preparations
  • Sector
  • NC Energy
  • CRVS Health Care
  • Exchange
  • NC Nasdaq
  • CRVS Nasdaq
  • Market Cap
  • NC 286.1M
  • CRVS 305.4M
  • IPO Year
  • NC N/A
  • CRVS 2016
  • Fundamental
  • Price
  • NC $39.14
  • CRVS $5.75
  • Analyst Decision
  • NC
  • CRVS Strong Buy
  • Analyst Count
  • NC 0
  • CRVS 4
  • Target Price
  • NC N/A
  • CRVS $15.00
  • AVG Volume (30 Days)
  • NC 6.0K
  • CRVS 518.7K
  • Earning Date
  • NC 10-29-2025
  • CRVS 08-07-2025
  • Dividend Yield
  • NC 2.58%
  • CRVS N/A
  • EPS Growth
  • NC N/A
  • CRVS N/A
  • EPS
  • NC 4.23
  • CRVS N/A
  • Revenue
  • NC $265,880,000.00
  • CRVS N/A
  • Revenue This Year
  • NC N/A
  • CRVS N/A
  • Revenue Next Year
  • NC N/A
  • CRVS N/A
  • P/E Ratio
  • NC $9.25
  • CRVS N/A
  • Revenue Growth
  • NC 27.25
  • CRVS N/A
  • 52 Week Low
  • NC $25.19
  • CRVS $2.54
  • 52 Week High
  • NC $45.50
  • CRVS $10.00
  • Technical
  • Relative Strength Index (RSI)
  • NC 55.37
  • CRVS 65.10
  • Support Level
  • NC $38.48
  • CRVS $5.28
  • Resistance Level
  • NC $39.31
  • CRVS $5.64
  • Average True Range (ATR)
  • NC 1.03
  • CRVS 0.30
  • MACD
  • NC 0.35
  • CRVS 0.03
  • Stochastic Oscillator
  • NC 85.68
  • CRVS 77.70

About NC NACCO Industries Inc.

NACCO Industries Inc is a holding company that operates in the mining and natural resource industries. It has three operating segments that are coal mining, North American mining (NA mining), and minerals management. The majority of its revenue is from the coal mining segment. This segment operates surface coal mines under long-term contracts with power generation companies and an activated carbon producer pursuant to a service-based business model. The NA mining segment provides value-add contract mining and services for producers. Minerals management generates income from royalty-based leases by acquiring and promoting oil, gas, and coal mineral interests. The company is diversifying beyond coal mining due to political and economic pressures associated with carbon emissions.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

Share on Social Networks: